Skip to main content

Four become one in Seqens

Pharmaceutical synthesis and speciality ingredients firm Novacap has announced that it is combining all of its CDMO subsidiaries

Cambrex expands in analytics

API and finished dosage form manufacturer Cambrex is investing $1 million at its site in High Point, North Carolina, in response to a growing number of new projects.

Lonza plans China biologics facility

Lonza Pharma & Biotech has concluded an agreement, under which GE Healthcare will deliver an off-the-shelf biologics facility to it in Guangzhou, China, by 2020. The company said that the new facility would give it “a strategic base in China to respond to growing demand for high-quality CDMO services in the country”.

Subscribe to Pharmaceuticals

 

 

 

AMRI banner advert